Overview

Vardenafil in Tinnitus

Status:
Completed
Trial end date:
2007-05-01
Target enrollment:
Participant gender:
Summary
There is incidental evidence (casuistic findings) that the treatment with vardenafil of male patients suffering from erectile dysfunction and comorbid tinnitus experienced an improvement of their tinnitus. Randomized, parallel-group, double-blind, placebo-controlled trial over 16 weeks (12 weeks of treatment + 4 weeks follow-up) with 10 mg vardenafil BID p.o. in men and women with chronic tinnitus.
Phase:
Phase 2
Details
Lead Sponsor:
Bayer
Treatments:
Vardenafil Dihydrochloride